CORBF (Global Cord Blood) EBIT per Share: $0.78 (TTM As of Mar. 2022)

What is Global Cord Blood EBIT per Share?

Global Cord Blood CORBF 12 EBIT per Share is $0.78 as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Global Cord Blood's EBIT per Share for the three months ended in Mar. 2022 was $0.18. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $0.78.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Global Cord Blood's EBIT per Share or its related term are showing as below:

CORBF's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 12.75
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Global Cord Blood's EBIT for the three months ended in Mar. 2022 was $22.4 Mil.

Global Cord Blood (OTCPK:CORBF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Global Cord Blood EBIT per Share Related Terms

Global Cord Blood EBIT per Share Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood EBIT per Share Chart

Global Cord Blood Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT per Share

Get a 7-Day Free Trial

0.41

0.47

0.66

0.69

0.79

Global Cord Blood Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EBIT per Share	Get a 7-Day Free Trial															0.19	0.20	0.20	0.19	0.18

12GF Score

Global Cord Blood Corp CORBF

EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Global Cord Blood EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Global Cord Blood's EBIT per Share for the fiscal year that ended in Mar. 2022 is calculated as

	EBIT per Share		(A: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	95.966	/	121.551
=	0.79

Global Cord Blood's EBIT per Share for the quarter that ended in Mar. 2022 is calculated as

	EBIT per Share		(Q: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	22.403	/	121.466
=	0.18

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.78

Frequently Asked Questions Learn more about EBIT per Share →

What does a EBIT per Share of $0.78 mean?

Global Cord Blood (CORBF) has a EBIT per Share of $0.78 as of Mar. 2022. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Global Cord Blood and its competitors.

Is Global Cord Blood's EBIT per Share too high?

Global Cord Blood's current EBIT per Share is $0.78. The Medical Diagnostics & Research industry median EBIT per Share is 12.75. Global Cord Blood's value of $0.78 is 93.9% below this industry median. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Global Cord Blood's EBIT per Share compare to PRE and LMDX?

Global Cord Blood's EBIT per Share of $0.78 can be compared against companies in the Medical Diagnostics & Research industry. The industry median EBIT per Share is 12.75. Global Cord Blood's value of $0.78 is 93.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT per Share for a Medical Diagnostics & Research company?

The median EBIT per Share among Medical Diagnostics & Research companies is 12.75, based on 168 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Cord Blood's current EBIT per Share of $0.78 is 93.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT per Share mean?

A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Global Cord Blood and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Cord Blood's current EBIT per Share is $0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Global Cord Blood stock overvalued right now?

Global Cord Blood (CORBF) has a current EBIT per Share of $0.78. The current EBIT per Share is $0.78 and 93.9% below the Medical Diagnostics & Research industry median of 12.75. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT per Share calculated?

EBIT per Share is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current EBIT per Share is $0.78 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies PRE LMDX NOTV NVTA BNR CSTL BGLC AKU BNGO PSNL TMO DHR A IQV XSWX:LONN ILMN IDXX SHSE:603259 MTD LH

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG

Website http://www.globalcordbloodcorp.com

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.

12GF Score

Get the complete analysis for CORBF

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95

Price

View CORBF Analysis

See EBIT per Share data for all stocks →